ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,779Medicare Part D Prescriptions Filled, Including Refills

Rank: 442 out of 5176

$941K Total Retail Price of All Prescriptions

Rank: 306 out of 5176

393 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
83% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 11,473 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

37% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$80 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
SIMVASTATIN 609 599 1 1
AMLODIPINE BESYLATE 529 525 2 2
LOSARTAN POTASSIUM 452 437 3 14
ZOLPIDEM TARTRATE 390 381 4 17
JANUVIA 381 372 5 25
ALLOPURINOL 292 292 6 41
ATORVASTATIN CALCIUM 269 265 7 9
ALENDRONATE SODIUM 255 255 8 18
EVISTA 230 230 9 65
METOPROLOL SUCCINATE 215 214 10 11
OMEPRAZOLE 206 206 11 3
GLIMEPIRIDE 197 190 12 37
CIPROFLOXACIN HCL 190 184 13 84
DIOVAN 176 176 14 19
EXFORGE 171 171 15 126
LEVOTHYROXINE SODIUM 166 166 16 4
TAMSULOSIN HCL 163 148 17 20
CLOPIDOGREL 135 133 18 26
ATENOLOL 127 123 19 12
LIDOCAINE-PRILOCAINE 125 125 20 340
PLAVIX 125 125 20 29
DONEPEZIL HCL 123 123 22 28
LOVAZA 119 115 23 43
CHLORHEXIDINE GLUCONATE 116 110 24 202
PROAIR HFA 113 113 25 60
RANITIDINE HCL 108 108 26 36
LIDODERM 107 107 27 59
POLYETHYLENE GLYCOL 3350 104 104 28 74
ZENPEP 102 102 29 372
AMMONIUM LACTATE 98 96 30 91
DILTIAZEM 24HR CD 98 98 30 119
MECLIZINE HCL 96 94 32 81
ENALAPRIL MALEATE 93 93 33 22
CARVEDILOL 90 90 34 24
NEXIUM 90 80 34 16
SINGULAIR 89 89 36 62
POTASSIUM CHLORIDE 88 88 37 34
FLUTICASONE PROPIONATE 86 83 38 38
MOMETASONE FUROATE 85 79 39 251
JANUMET 80 71 40 77
ISOSORBIDE MONONITRATE ER 80 80 40 44
GABAPENTIN 78 78 42 21
METOPROLOL TARTRATE 73 63 43 6
VOLTAREN 71 71 44 97
BISOPROLOL-HYDROCHLOROTHIAZIDE 70 69 45 164
ACTOS 69 69 46 85
PRANDIN 68 65 47 150
LIPITOR 67 67 48 51
DIGOXIN 65 65 49 56
LOSARTAN-HYDROCHLOROTHIAZIDE 64 59 50 35
METFORMIN HCL ER 63 48 51 57
FLUOXETINE HCL 62 62 52 132
CEFUROXIME 62 61 52 273
NITROGLYCERIN PATCH 60 60 54 149
BETAMETHASONE DIPROPIONATE 60 57 54 260
ADVAIR DISKUS 56 56 56 32
ALBUTEROL SULFATE 55 55 57 99
PRAVASTATIN SODIUM 55 55 57 23
FELODIPINE ER 54 54 59 128
PANTOPRAZOLE SODIUM 53 50 60 61
WARFARIN SODIUM 52 52 61 13
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 29, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.